Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 221.90M | $ 9.30M | $ 77.65M | $ 69.72M | $ 8.25M |
| Gross Profit | $ 218.02M | $ 6.86M | $ 74.21M | $ 66.60M | $ 8.25M |
| Operating Income | $ -592.97M | $ -607.37M | $ -512.20M | $ -576.63M | $ -474.48M |
| EBITDA | $ -436.83M | $ -565.47M | $ -397.44M | $ -533.83M | $ -467.38M |
| Net Income | $ -535.76M | $ -643.20M | $ -481.18M | $ -562.54M | $ -448.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 681.10M | $ 434.88M | $ 471.92M | $ 836.66M | $ 607.09M |
| Total Assets | $ 919.34M | $ 546.38M | $ 623.04M | $ 1.01B | $ 703.59M |
| Total Debt | $ 1.73B | $ 1.74B | $ 1.72B | $ 1.73B | $ 495.79M |
| Net Debt | $ 1.05B | $ 1.36B | $ 1.35B | $ 1.33B | $ 139.71M |
| Total Liabilities | $ 2.38B | $ 1.89B | $ 1.87B | $ 1.88B | $ 595.70M |
| Stockholders' Equity | $ -1.47B | $ -1.35B | $ -1.25B | $ -870.41M | $ 57.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -521.66M | $ -529.03M | $ -425.81M | $ -546.18M | $ -407.23M |
| Operating Cash Flow | $ -520.73M | $ -527.72M | $ -419.49M | $ -497.93M | $ -399.71M |
| Investing Cash Flow | $ 60.78M | $ 54.03M | $ 453.15M | $ -200.83M | $ -52.99M |
| Financing Cash Flow | $ 748.46M | $ 451.54M | $ -13.13M | $ 736.45M | $ 447.19M |
BridgeBio Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.